enGene Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul '24 Jul 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020
Net Income	-122.34	-99.92	-24.46	-23.44	-15.07
Depreciation & Amortization	0.29	0.18	0.24	0.27	0.26
Other Amortization	-	0.92	-	-	-
Stock-Based Compensation	7.02	3.45	0.12	0.44	0.15
Other Operating Activities	70.79	71.14	4.34	7.79	1.21
Change in Accounts Payable	1.32	0.37	-0.2	0.11	0.22
Change in Other Net Operating Assets	5.12	0.12	2.23	-1.44	0.31
Operating Cash Flow	-35.49	-24.74	-17.59	-15.98	-13.06
Capital Expenditures	-0.83	-0.32	-0.15	-0.25	-0.19
Sale of Property, Plant & Equipment	-	-	-	0	-
Investing Cash Flow	-0.83	-0.32	-0.15	-0.25	-0.19
Long-Term Debt Issued	-	38	29.4	8.03	13.01
Long-Term Debt Repaid	-	-4.73	-1.01	-0.96	-
Net Debt Issued (Repaid)	8.71	33.27	28.39	7.07	13.01
Issuance of Common Stock	263	56.94	0.01	0.01	-
Other Financing Activities	-15.32	-4.06	-0.44	-0.14	-0.16
Financing Cash Flow	256.4	86.15	27.97	22.53	12.85
Foreign Exchange Rate Adjustments	0	0	-0.81	0.1	-0.05
Net Cash Flow	220.08	61.09	9.42	6.39	-0.46
Free Cash Flow	-36.31	-25.06	-17.75	-16.23	-13.25
Free Cash Flow Per Share	-1.35	-36.18	-27.09	-4.56	-4.80
Cash Interest Paid	1.85	1.4	0.62	-	-
Levered Free Cash Flow	-23.58	-16.07	-10.75	-	-
Unlevered Free Cash Flow	-21.58	-13.89	-9.86	-	-
Change in Net Working Capital	-6.49	0.91	-2.08	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.